STOCK TITAN

Envista Holdings Corporation - NVST STOCK NEWS

Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.

Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company committed to empowering dental professionals worldwide. Headquartered in Brea, California, Envista develops, manufactures, and markets an extensive portfolio of dental consumables, equipment, and services. The company operates through two primary segments: Specialty Products & Technologies and Equipment & Consumables.

The Specialty Products & Technologies segment focuses on dental implant systems, regenerative solutions, dental prosthetics, orthodontic systems, and lab products. This segment is dedicated to advancing the capabilities of dental professionals through innovative products and technologies.

The Equipment & Consumables segment offers a broad range of dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, supporting the diagnostic, treatment, and prevention needs of dental conditions.

Envista has a strong commitment to continuous improvement, action-oriented innovation, and a deep respect for dental professionals. Its comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs, ensuring a holistic approach to dental care.

Recent achievements include the launch of the DEXIS digital ecosystem, an AI-powered platform designed to streamline implant dentistry workflows. This interconnected system combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning, empowering clinicians to manage implant cases efficiently.

Envista continues to innovate with products like the ORTHOPANTOMOGRAPH™ OP 3D™ LX, which enhances 3D diagnostic capabilities, and the IS ScanFlow software, which integrates AI-driven tools to maximize productivity in dental practices.

Financially, Envista reported sales of $623.6 million for the first quarter of 2024, with core sales growth and ongoing investments aimed at accelerating growth and profitability. The company has a proven track record of resilience and strategic differentiation, particularly through the challenges posed by the global pandemic and other economic factors.

Envista's philanthropic arm, the Envista Smile Project, exemplifies its commitment to social responsibility. The project has donated millions to improve access to oral health for underserved communities, partnering with institutions like the University of Southern California to enhance dental care for vulnerable populations.

Envista's significant market positions in attractive dental segments, coupled with its continuous improvement culture and innovation-driven approach, make it a pivotal player in the dental industry. For more information, visit the official website at www.envistaco.com.

Rhea-AI Summary

Envista Holdings (NYSE: NVST) has announced three key leadership appointments, effective in July and August 2024. Eric Hammes joins as Chief Financial Officer, bringing over 25 years of operational and financial leadership experience from Rockwell Automation and 3M. Stefan Nilsson becomes President of Nobel Biocare, with a background as CEO of Colosseum Dental Group and GrandVision Brazil. Veronica Acurio is appointed President of Orthodontics, joining from Solventum with extensive experience in global healthcare businesses, including leadership roles at 3M.

These appointments aim to strengthen Envista's position in dental implants, orthodontics, and overall financial performance. CEO Paul Keel expressed confidence that these leaders will help accelerate growth, expand margins, and advance the company's portfolio in the dental industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
none
-
Rhea-AI Summary

Envista Holdings (NYSE: NVST) will announce its second quarter 2024 financial results on Wednesday, August 7, 2024. The company has scheduled a conference call for the same day at 2:00 PM PT to discuss these results. The call will include a slide presentation and will be available via webcast on the 'Investors' section of Envista's website. A replay of the webcast will be accessible shortly after the call and will be available for one year. To join the call, dial 800-579-2543 (U.S.) or +1 785-424-1789 (international) and refer to conference ID #9467851. Presentation materials will be available on the company's website before the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
-
Rhea-AI Summary

Envista Holdings (NYSE: NVST) and its charitable branch, the Envista Smile Project, announced a $2.1 million donation to the University of Southern California's (USC) Herman Ostrow School of Dentistry.

This donation aims to support the Dental Health Equity and Access to Care Initiative, focusing on underserved communities, particularly children with special needs in California. The three-year donation will provide essential oral health equipment, products, and technology updates. It will also expand the USC Pediatric Clinic and Mobile Clinic, enhancing services for special needs patients, telehealth, and general care for vulnerable populations.

This partnership includes other philanthropic endeavors, like medical mission trips staffed by USC students and faculty, to bring oral care to international communities in need.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.17%
Tags
none
Rhea-AI Summary

Envista Holdings (NYSE: NVST) announced its participation in the Stifel Jaws & Paws Conference, scheduled for May 29, 2024. The event will include a Fireside Chat from 4:10 to 4:40 pm ET. An audio-only recording of the session will be available on the company's Investor Relations website for up to 365 days after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none
-
Rhea-AI Summary

Envista Holdings (NYSE: NVST) reported sales of $623.6 million for the first quarter of 2024, with a 0.4% increase in core sales compared to 2023. Net income was $23.6 million, adjusted net income $45.8 million, and adjusted EBITDA $87.2 million. The company appointed Paul Keel as the new CEO. Envista remains focused on growth and profitability with a strong outlook for the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
-
News
Rhea-AI Summary
Envista Holdings (NVST) announced the appointment of Paul Keel as CEO and Board member, effective May 1, 2024. Keel brings a strong track record in global innovation and medical markets, aiming to digitize dental care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
none
Rhea-AI Summary
Envista Holdings (NVST) announced that the Envista Smile Project donated $1.2 million in 2023 to improve access to oral health. The donations more than doubled from 2022, reaching over $2.2 million in total value of goods and services since 2021. The Smile Project provided dental care, goods, and funds to various organizations globally, impacting over 19,000 patients in need.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.53%
Tags
none
-
Rhea-AI Summary
Envista Holdings (NVST) will release its first-quarter 2024 financial results on May 1, 2024. The conference call to discuss these results will be held at 2:00 PM PT. The webcast will be available on Envista's website, with a replay option. Investors can access the call via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
-
Rhea-AI Summary
DEXIS introduces IS ScanFlow v.1.0.10, enhancing dental implant workflows with guided workflows and AI capabilities. The update aims to boost productivity for clinicians by simplifying data capture in complex situations, automating manual tasks, and facilitating efficient lab communication. Early adopters have provided positive feedback on the system's ease of use and accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
Rhea-AI Summary
Envista Holdings Corporation (NVST) has initiated the process to select a new CEO to succeed Amir Aghdaei, who will continue as President until the appointment. The board is actively searching for external candidates to drive the company's future growth and transformation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none

FAQ

What does Envista Holdings Corporation do?

Envista Holdings Corporation develops, manufactures, and markets dental consumables, equipment, and services to dental professionals worldwide.

What are the main segments of Envista's business?

Envista operates through two primary segments: Specialty Products & Technologies, and Equipment & Consumables.

What recent achievements has Envista made?

Recently, Envista launched the DEXIS digital ecosystem, an AI-powered platform for implant dentistry, and the ORTHOPANTOMOGRAPH™ OP 3D™ LX for enhanced 3D diagnostics.

How did Envista perform financially in the first quarter of 2024?

Envista reported sales of $623.6 million, with a net income of $23.6 million or $0.14 per diluted share for the first quarter of 2024.

What is the Envista Smile Project?

The Envista Smile Project is a philanthropic foundation aimed at improving oral health for disadvantaged communities through donations and medical mission trips.

Who is the new CEO of Envista Holdings Corporation?

Paul Keel was appointed as the new CEO of Envista Holdings Corporation effective May 1, 2024.

How does Envista support dental professionals?

Envista supports dental professionals by providing a comprehensive portfolio of dental consumables, solutions, technology, and services.

What is the DEXIS digital ecosystem?

The DEXIS digital ecosystem is an interconnected, AI-powered platform designed to streamline and manage the implant dentistry workflow.

What is the Envista Business System (EBS)?

The Envista Business System (EBS) is a methodology that underpins the company's operations, focusing on continuous improvement and innovation.

Where can I find more information about Envista Holdings Corporation?

For more information, please visit Envista's official website at www.envistaco.com.

Envista Holdings Corporation

NYSE:NVST

NVST Rankings

NVST Stock Data

2.80B
171.86M
0.47%
108.72%
5.18%
Dental Equipment and Supplies Manufacturing
Manufacturing
Link
United States of America
BREA